Atlas Trials

Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer

Clinical trial NCT00536614 · COMPLETED

Trial details

NCT number
NCT00536614
Sponsor
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2005-05-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.